COPD exacerbation medications (BNF)
Codelist metadata
-
Coding system
- Pseudo BNF
-
Coding system release
- 84 (2023-02-01)
-
Organisation
- University of Bristol
-
Codelist ID
- bristol/copd-exacerbation-medications-bnf
-
Version ID
- 31f0f047
Versions
About
Description
COPD exacerbation medication codes derived by Hannah Whittaker (Imperial College London) and reviewed by Jenni Quint (Imperial College London) for CONVALESENCE Long Covid EHR project
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
code | term |
---|---|
0501011J0 | Benzylpenicillin sodium (Penicillin G) |
0501011P0 | Phenoxymethylpenicillin (Penicillin V) |
0501012G0 | Flucloxacillin sodium |
0501012H0 | Flucloxacillin magnesium |
0501012U0 | Temocillin sodium |
0501013B0 | Amoxicillin |
0501013C0 | Amoxicillin sodium |
0501013E0 | Ampicillin |
0501013K0 | Co-amoxiclav (Amoxicillin/clavulanic acid) |
0501013L0 | Co-fluampicil(Flucloxacillin/ampicillin) |
0501014N0 | Ticarcillin with clavulanic acid |
0501014S0 | Piperacillin sodium/tazobactam sodium |
0501015P0 | Pivmecillinam hydrochloride |
0603020T0 | Prednisolone |
0603020X0 | Prednisone |
Codes not in the full codelist are in faint grey.